.
Feedback Survey
Application 1393 – Cardiac MRI Cardiomyopathy
Thank you for taking the time to complete this feedback form on a draft protocol to consider the options by
which a new intervention might be subsidised through the use of public funds. You are welcome to provide
feedback from either a personal or group perspective for consideration by the Protocol Advisory SubCommittee (PASC) of MSAC when the draft protocol is being reviewed.
The data collected will be used to inform the MSAC assessment process to ensure that when proposed
healthcare interventions are assessed for public funding in Australia, they are patient focused and seek to
achieve best value.
This feedback form should take 10-12 minutes to complete.
You may also wish to supplement your responses with further documentation or diagrams or other information
to assist PASC in considering your feedback.
Responses will be provided to the MSAC , its subcommittees and the applicant with responses identified unless
you specifically request deidentification.
While stakeholder feedback is used to inform the application process, you should be aware that your feedback
may be used more broadly by the applicant.
Please reply to the HTA Team
Postal: MDP 853 GPO 9848 Canberra ACT 2601
Fax: 02 6289 3561
Phone 02 6289 7550
Email: HTA@health.gov.au
Your feedback is requested by 21 March 2015 to enable the collation of responses to be provided to PASC to
consider during its deliberations.
PERSONAL AND ORGANISATIONAL INFORMATION
1.
What is your name? ____________________________________________________________________
2.
Is the feedback being provided on an individual basis or by a collective group?
 Individual
 Collective group. Specify name of group (if applicable) __________________________________________
What is the name of the organisation you work for (if applicable)? ____________________________________
4.
What is your e-mail address? _____________________________________________________________
5.
Are you a:
a.
General practitioner
b.
Specialist
c.
Researcher
d.
Consumer
e.
Care giver
f.
Other (please specify) _______________________________________________________
1
Feedback Survey
MEDICAL CONDITION (DISEASE):
Non-ischemic Cardiomyopathy
PROPOSED INTERVENTION:
Cardiac Magnetic Resonance Imaging (CMRI)
CLINICAL NEED AND PUBLIC HEALTH SIGNIFICANCE
1) Describe your experience with the medical condition (disease) and/or proposed intervention relating to
the draft protocol?
2) What do you see as the benefits of this proposed intervention for the person involved and/or their family
and carers?
3) What do you see as the disadvantages of this proposed intervention for the person involved and/or their
family and carers?
4) How do you think a person’s life and that of their family and/or carers can be improved by this proposed
intervention?
5) What other benefits can you see from having this proposed intervention publicly funded on the
Medicare Benefits Schedule (MBS)?
INDICATION(S) FOR THE PROPOSED INTERVENTION AND CLINICAL CLAIM
Flowcharts of current management and potential management with the proposed intervention for these medical
conditions can be found on pages 19 (dilated cardiomyopathy), 23 (hypertrophic cardiomyopathy), 28
(arrhythmogenic right-ventricular cardiomyopathy), 32 (troponin-positive chest pain), and 35 (family history).
6) Do you agree or disagree with the eligible populations for the proposed intervention as specified in the
proposed management flowcharts?
 Strongly agree
 Agree
 Disagree
 Strongly disagree
2
Feedback Survey
Why or why not? Please specify which sub-population(s) you wish to comment on.
7) Do you agree or disagree with the comparators for the proposed intervention as specified in the current
management flowcharts?
 Strongly agree
 Agree
 Disagree
 Strongly disagree
Why or why not? Please specify which comparators you wish to comment on.
8) Do you agree or disagree with the clinical claims (outcomes) made for the proposed intervention?
 Strongly agree
 Agree
 Disagree
 Strongly disagree
Why or why not? Please specify which outcomes you wish to comment on.
9) Have all associated interventions been adequately captured in the flowcharts?
 Yes
 No
If not, please move any misplaced interventions, remove any superfluous intervention, or suggest any
missing interventions to indicate how they should be captured on the flowcharts. Please explain the
rationale behind each of your modifications.
3
Feedback Survey
ADDITIONAL QUESTIONS FOR PASC SPECIFIC TO THIS PROPOSAL.
The application notes that for some sub-populations the benefits of CMRI, in terms of any potential change in
management compared to comparators, can be difficult to quantify. The benefits of the change in management
to patient health outcomes are similarly difficult to define. Where possible, the applicant has provided an
estimate based on clinical expertise.
10) Do you agree or disagree with the quantitative estimates of the impact that CMRI has on treatment
outcomes in Australia for all of the sub-populations?
11) Would you suggest any alternative estimates? Please provide sources if possible.
The application raises concerns regarding the availability of appropriate CMRI equipment.
12) Please highlight specific concerns about the availability of CMRI equipment or the capacity to upgrade
existing equipment with CMRI components.
13) Do you think that the quality of images produced using thoracic coils is equivalent to the quality of
images produced using cardiac coils? If not, please indicate if there are any scenarios in which the
difference would impact on clinical management.
Public consultation feedback is sought to determine whether there is a more robust way to estimate the size of
each proposed population, and to confirm whether all of the costs/resources associated with the proposed
service have been captured:
14) It is currently unclear what the estimated utilisation of CMRI for the investigation of cardiomyopathies
is likely to be, specifically in regards to the size of each proposed population. Limitations in the
epidemiological data of disease incidence and prevalence make it difficult to estimate the number of
new cases likely to utilise the proposed service. The population estimates for the sub-populations are
based on hospital separations (see pages 9-10). There is little data available to corroborate these
estimates. Do you agree or disagree with the estimates provided? Is it possible to provide a more robust
estimate of the expected utilisation of CMRI in each population?
15) It is unclear what proportion of family members will choose to undergo CMRI following a confirmed
diagnosis of a familial cardiomyopathy subtype or sudden cardiac death in a first-degree relative
(excluding Population Four). Is there a reliable way to estimate the size of these populations?
4
Feedback Survey
16) Are there any costs or resources associated with the proposed service, comparators, or treatments that
have not been captured in Table 8?
17) Should the proposed MBS items be expanded to allow GP referral? Do you have any comments on the
appropriate training requirements for referring doctors?
ADDITIONAL COMMENTS
18) Do you have any additional comments on the proposed intervention and/or medical condition (disease)
relating to the proposed intervention?
19) Do you have any comments on this feedback form and process? Please provide comments or
suggestions on how this process could be improved.
Thank you again for taking the time to provide your valuable feedback.
If you experience any problems completing this on-line survey please contact the HTA Team
Phone 02 6289 7550
Postal: MDP 853 GPO 9848 Canberra ACT 2601
Fax: 02 6289 3561
Email: HTA@health.gov.au
5